HS-20152
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 01, 2026
Phase 1 Study of HS-20152 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
First-in-human • New P1 trial
1 to 1
Of
1
Go to page
1